FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310183461> ?p ?o ?g. }

• W4310183461 abstract "Introduction The possibility that asthma is not a risk factor for the worst outcomes due to coronavirus disease (COVID-19) is encouraged. The increase in Th2 response dominance can downregulate the late phase of hyperinflammation, which is typically the hallmark of more severe respiratory viral infections, alongside lower angiotensin-converting enzyme receptors in patients with asthma due to chronic inflammation. Few studies associated asthma diagnosis and COVID-19 outcomes. In this context, we aimed to associate the asthma phenotype with the clinical signs, disease progression, and outcomes in patients with COVID-19. Methods We performed an epidemiologic study using patients’ characteristics from OpenDataSUS to verify the severity of COVID-19 among Brazilian hospitalized patients with and without the asthma phenotype according to the need for intensive care units, intubation, and deaths. We also evaluated the demographic data (sex, age, place of residence, educational level, and race), the profile of clinical signs, and the comorbidities. Results Asthma was present in 43,245/1,129,838 (3.8%) patients. Among the patients with asthma, 74.7% who required invasive ventilatory support evolved to death. In contrast, 78.0% of non-asthmatic patients who required invasive ventilatory support died (OR = 0.83; 95% CI = 0.79–0.88). Also, 20.0% of the patients with asthma that required non-invasive ventilatory support evolved to death, while 23.5% of non-asthmatic patients evolved to death (OR = 0.81; 95% CI = 0.79–0.84). Finally, only 11.2% of the patients with asthma who did not require any ventilatory support evolved to death, while 15.8% of non-asthmatic patients evolved to death (OR = 0.67; 95% CI = 0.62–0.72). In our multivariate analysis, one comorbidity and one clinical characteristic stood out as protective factors against death during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Patients with asthma were less prone to die than other patients (OR = 0.79; 95% CI = 0.73–0.85), just like puerperal patients (OR = 0.74; 95% CI = 0.56–0.97) compared to other patients. Conclusion Asthma was a protective factor for death in hospitalized patients with COVID-19 in Brazil. Despite the study’s limitations on patients’ asthma phenotype information and corticosteroid usage, this study brings to light information regarding a prevalent condition that was considered a risk factor for death in COVID-19, being ultimately protective." @default.
• W4310183461 created "2022-11-30" @default.
• W4310183461 creator A5011593741 @default.
• W4310183461 creator A5019314219 @default.
• W4310183461 creator A5020907087 @default.
• W4310183461 creator A5078181683 @default.
• W4310183461 creator A5084384397 @default.
• W4310183461 date "2022-11-29" @default.
• W4310183461 modified "2023-10-17" @default.
• W4310183461 title "Profile of coronavirus disease enlightened asthma as a protective factor against death: An epidemiology study from Brazil during the pandemic" @default.
• W4310183461 cites W1596555805 @default.
• W4310183461 cites W2049902839 @default.
• W4310183461 cites W2073310243 @default.
• W4310183461 cites W2089709635 @default.
• W4310183461 cites W2110039310 @default.
• W4310183461 cites W2114608816 @default.
• W4310183461 cites W2141479546 @default.
• W4310183461 cites W2258078352 @default.
• W4310183461 cites W2267315119 @default.
• W4310183461 cites W2306338343 @default.
• W4310183461 cites W2322237719 @default.
• W4310183461 cites W2411471160 @default.
• W4310183461 cites W2789180591 @default.
• W4310183461 cites W2886563812 @default.
• W4310183461 cites W2890432357 @default.
• W4310183461 cites W3002108456 @default.
• W4310183461 cites W3007814559 @default.
• W4310183461 cites W3013870011 @default.
• W4310183461 cites W3014007058 @default.
• W4310183461 cites W3016785135 @default.
• W4310183461 cites W3018158967 @default.
• W4310183461 cites W3019049622 @default.
• W4310183461 cites W3022455098 @default.
• W4310183461 cites W3029533207 @default.
• W4310183461 cites W3033767101 @default.
• W4310183461 cites W3033968556 @default.
• W4310183461 cites W3035609360 @default.
• W4310183461 cites W3037718428 @default.
• W4310183461 cites W3038328918 @default.
• W4310183461 cites W3043002108 @default.
• W4310183461 cites W3043460025 @default.
• W4310183461 cites W3046581048 @default.
• W4310183461 cites W3048804923 @default.
• W4310183461 cites W3080487846 @default.
• W4310183461 cites W3081892893 @default.
• W4310183461 cites W3082884421 @default.
• W4310183461 cites W3087217019 @default.
• W4310183461 cites W3089128525 @default.
• W4310183461 cites W3092606398 @default.
• W4310183461 cites W3095294553 @default.
• W4310183461 cites W3097377808 @default.
• W4310183461 cites W3097781093 @default.
• W4310183461 cites W3101354864 @default.
• W4310183461 cites W3110738325 @default.
• W4310183461 cites W3110755304 @default.
• W4310183461 cites W3118433754 @default.
• W4310183461 cites W3119604045 @default.
• W4310183461 cites W3119939619 @default.
• W4310183461 cites W3126464145 @default.
• W4310183461 cites W3128015881 @default.
• W4310183461 cites W3133879942 @default.
• W4310183461 cites W3135580011 @default.
• W4310183461 cites W3137050976 @default.
• W4310183461 cites W3148512227 @default.
• W4310183461 cites W3156655166 @default.
• W4310183461 cites W3157070895 @default.
• W4310183461 cites W3173683321 @default.
• W4310183461 cites W3177518135 @default.
• W4310183461 cites W3188444363 @default.
• W4310183461 cites W3190164270 @default.
• W4310183461 cites W3198658148 @default.
• W4310183461 cites W3209840591 @default.
• W4310183461 cites W3213129005 @default.
• W4310183461 cites W3215606845 @default.
• W4310183461 cites W4200152787 @default.
• W4310183461 cites W4205140567 @default.
• W4310183461 cites W4206381113 @default.
• W4310183461 cites W4229001788 @default.
• W4310183461 cites W4280492581 @default.
• W4310183461 cites W4281297761 @default.
• W4310183461 cites W4283647331 @default.
• W4310183461 cites W4283727019 @default.
• W4310183461 cites W4283785043 @default.
• W4310183461 cites W4285719527 @default.
• W4310183461 cites W4286462087 @default.
• W4310183461 cites W4286817027 @default.
• W4310183461 doi "https://doi.org/10.3389/fmed.2022.953084" @default.
• W4310183461 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36523782" @default.
• W4310183461 hasPublicationYear "2022" @default.
• W4310183461 type Work @default.
• W4310183461 citedByCount "1" @default.
• W4310183461 crossrefType "journal-article" @default.
• W4310183461 hasAuthorship W4310183461A5011593741 @default.
• W4310183461 hasAuthorship W4310183461A5019314219 @default.
• W4310183461 hasAuthorship W4310183461A5020907087 @default.
• W4310183461 hasAuthorship W4310183461A5078181683 @default.
• W4310183461 hasAuthorship W4310183461A5084384397 @default.
• W4310183461 hasBestOaLocation W43101834611 @default.
• W4310183461 hasConcept C107130276 @default.
• W4310183461 hasConcept C126322002 @default.

• next